NCT06843967 2026-03-13A Study of Mirdametinib in Combination With Palbociclib in People With LiposarcomaMemorial Sloan Kettering Cancer CenterPhase 1/2 Recruiting54 enrolled
NCT06113809 2025-06-03Palbociclib and Pembrolizumab in SarcomaUniversity of IowaPhase 1 Recruiting8 enrolled